AxioMed introduced its lateral total disc replacement, for which first surgery completion is expected by year-end in Jamaica.
The company is expanding its executive team to oversee commercialization of the disc ex-U.S., while pursuing a 2018 FDA Premarket Approval for the device.
AxioMed recently closed a first investment round and opened a second $10.0MM round to support ex-U.S. commercialization and U.S. cervical Investigational Device Exemption study.
Sources: AxioMed LLC; ORTHOWORLD Inc.
AxioMed's Lateral Approach to TDR, courtesy of AxioMed LLC